These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25244568)

  • 1. From the mouse cage to human therapy: a personal perspective of the emergence of T-bodies/chimeric antigen receptor T cells.
    Eshhar Z
    Hum Gene Ther; 2014 Sep; 25(9):773-8. PubMed ID: 25244568
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring synthetic immunity: From boutique to global.
    Levine BL
    Hum Vaccin Immunother; 2017 Oct; 13(10):2204-2206. PubMed ID: 28945504
    [No Abstract]   [Full Text] [Related]  

  • 3. Adoptive cell therapy: Honing that killer instinct.
    Humphries C
    Nature; 2013 Dec; 504(7480):S13-5. PubMed ID: 24352359
    [No Abstract]   [Full Text] [Related]  

  • 4. Adoptive transfer of virus-specific and tumor-specific T cell immunity.
    Berger C; Turtle CJ; Jensen MC; Riddell SR
    Curr Opin Immunol; 2009 Apr; 21(2):224-32. PubMed ID: 19304470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy for cancer.
    Ruella M; Kalos M
    Immunol Rev; 2014 Jan; 257(1):14-38. PubMed ID: 24329787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAR-modified T-cell therapy for cancer: an updated review.
    Haji-Fatahaliha M; Hosseini M; Akbarian A; Sadreddini S; Jadidi-Niaragh F; Yousefi M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1339-49. PubMed ID: 26068778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseases.
    Hombach A; Pohl C; Reinhold U; Abken H
    Hybridoma; 1999 Feb; 18(1):57-61. PubMed ID: 10211789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.
    Khalil DN; Smith EL; Brentjens RJ; Wolchok JD
    Nat Rev Clin Oncol; 2016 May; 13(5):273-90. PubMed ID: 26977780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAR T-cell Therapy: A New Era in Cancer Immunotherapy.
    Miliotou AN; Papadopoulou LC
    Curr Pharm Biotechnol; 2018; 19(1):5-18. PubMed ID: 29667553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges.
    Han EQ; Li XL; Wang CR; Li TF; Han SY
    J Hematol Oncol; 2013 Jul; 6():47. PubMed ID: 23829929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric antigen receptor T cell therapy: 25years in the making.
    Gill S; Maus MV; Porter DL
    Blood Rev; 2016 May; 30(3):157-67. PubMed ID: 26574053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric Antigen Receptor T-Cell Therapies Advancing.
    Brower V
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27920051
    [No Abstract]   [Full Text] [Related]  

  • 13. CARTs for Solid Tumors: Feasible or Infeasible?
    Li W; Song X; Jin Y; Li F; Yu H; Cao C; Jiang Q
    Oncol Res Treat; 2017; 40(9):540-546. PubMed ID: 28813706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.
    Chicaybam L; Sodré AL; Bonamino M
    Int Rev Immunol; 2011; 30(5-6):294-311. PubMed ID: 22053970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer).
    Guo ZS
    BMC Cancer; 2018 Nov; 18(1):1086. PubMed ID: 30415640
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award.
    Hurst JH
    J Clin Invest; 2015 Oct; 125(10):3732-6. PubMed ID: 26345422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cancer immunotherapy crowned with Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo].
    Teillaud JL
    Med Sci (Paris); 2019 Apr; 35(4):365-366. PubMed ID: 31038115
    [No Abstract]   [Full Text] [Related]  

  • 18. Armed T cells with CAR for cancer immunotherapy.
    Wei YQ
    Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712
    [No Abstract]   [Full Text] [Related]  

  • 19. CCR 20th Anniversary Commentary: Chimeric Antigen Receptors-From Model T to the Tesla.
    Hwu P
    Clin Cancer Res; 2015 Jul; 21(14):3099-101. PubMed ID: 26180056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric T-cell receptors: highly specific tools to target cytotoxic T-lymphocytes to tumour cells.
    Abken H; Hombach A; Heuser C; Sircar R; Pohl C; Reinhold U
    Cancer Treat Rev; 1997 Mar; 23(2):97-112. PubMed ID: 9225961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.